Shopping Cart 0
Cart Subtotal
USD 0

ResApp Health Ltd (RAP) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375

Details

ResApp Health Ltd (RAP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company develops diagnostic tools that require a smartphone. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, bronchitis, pneumonia, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp's technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and tele-health use through partnerships with tele-health service providers. ResApp is headquartered in Brisbane, Queensland, Australia.

ResApp Health Ltd Key Recent Developments

Oct 04,2019: ResApp selected to join the startup Creasphere Digital Health Program

Jul 29,2019: ResApp Health: Update for the quarter ending 30 June 2019

Jun 19,2019: ResApp Health: Extension of CEO and Managing Director's Contract

Jun 12,2019: ResApp receives USD 1.785 Million R&D tax incentive cash rebate

Jun 05,2019: ResApp appoints renowned healthcare leaders to industry advisory board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

ResApp Health Ltd-Key Facts

ResApp Health Ltd-Key Employees

ResApp Health Ltd-Key Employee Biographies

ResApp Health Ltd-Major Products and Services

ResApp Health Ltd-History

ResApp Health Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

ResApp Health Ltd-Business Description

ResApp Health Ltd-SWOT Analysis

SWOT Analysis-Overview

ResApp Health Ltd-Strengths

ResApp Health Ltd-Weaknesses

ResApp Health Ltd-Opportunities

ResApp Health Ltd-Threats

ResApp Health Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

ResApp Health Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 04, 2019: ResApp selected to join the startup Creasphere Digital Health Program

Jul 29, 2019: ResApp Health: Update for the quarter ending 30 June 2019

Jun 19, 2019: ResApp Health: Extension of CEO and Managing Director's Contract

Jun 12, 2019: ResApp receives USD 1.785 Million R&D tax incentive cash rebate

Jun 05, 2019: ResApp appoints renowned healthcare leaders to industry advisory board

Apr 30, 2019: ResApp Health: Update for the quarter ending 31 March 2019

Jan 29, 2019: ResApp Health: Update for the quarter ending 31 December 2018

Nov 05, 2018: ResApp receives notice of allowance for core patent in Japan

Aug 16, 2018: ResApp Partners with Lockheed Martin for U.S. Government Agency Research Program

Aug 15, 2018: ResApp receives notice of acceptance for core patent in Australia

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

ResApp Health Ltd, Performance Chart (2015-2019)

ResApp Health Ltd, Ratio Charts

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

ResApp Health Ltd, Key Facts

ResApp Health Ltd, Key Employees

ResApp Health Ltd, Key Employee Biographies

ResApp Health Ltd, Major Products and Services

ResApp Health Ltd, History

ResApp Health Ltd, Subsidiaries

ResApp Health Ltd, Key Competitors

ResApp Health Ltd, Ratios based on current share price

ResApp Health Ltd, Annual Ratios

ResApp Health Ltd, Annual Ratios (Cont...1)

ResApp Health Ltd, Interim Ratios

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

ResApp Health Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

ResApp Health Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Welch Allyn Inc

ResMed Inc

Genetic Signatures Ltd

GE Healthcare LLC

Alere Inc

ResApp Health Ltd (RAP)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseases. The company develops diagnostic tools that require a smartphone. ResApp has license from The University of Queensland for technology that uses sound to diagnose respiratory diseases including upper respiratory tract infections, bronchitis, pneumonia, asthma and chronic obstructive pulmonary disease (COPD). Markets for ResApp's technology include emergency department and regular clinic use by healthcare providers, at-home use by consumers and tele-health use through partnerships with tele-health service providers. ResApp is headquartered in Brisbane, Queensland, Australia.

ResApp Health Ltd Key Recent Developments

Oct 04,2019: ResApp selected to join the startup Creasphere Digital Health Program

Jul 29,2019: ResApp Health: Update for the quarter ending 30 June 2019

Jun 19,2019: ResApp Health: Extension of CEO and Managing Director's Contract

Jun 12,2019: ResApp receives USD 1.785 Million R&D tax incentive cash rebate

Jun 05,2019: ResApp appoints renowned healthcare leaders to industry advisory board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

ResApp Health Ltd-Key Facts

ResApp Health Ltd-Key Employees

ResApp Health Ltd-Key Employee Biographies

ResApp Health Ltd-Major Products and Services

ResApp Health Ltd-History

ResApp Health Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

ResApp Health Ltd-Business Description

ResApp Health Ltd-SWOT Analysis

SWOT Analysis-Overview

ResApp Health Ltd-Strengths

ResApp Health Ltd-Weaknesses

ResApp Health Ltd-Opportunities

ResApp Health Ltd-Threats

ResApp Health Ltd-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

ResApp Health Ltd, Recent Deals Summary

Section 5-Company's Recent Developments

Oct 04, 2019: ResApp selected to join the startup Creasphere Digital Health Program

Jul 29, 2019: ResApp Health: Update for the quarter ending 30 June 2019

Jun 19, 2019: ResApp Health: Extension of CEO and Managing Director's Contract

Jun 12, 2019: ResApp receives USD 1.785 Million R&D tax incentive cash rebate

Jun 05, 2019: ResApp appoints renowned healthcare leaders to industry advisory board

Apr 30, 2019: ResApp Health: Update for the quarter ending 31 March 2019

Jan 29, 2019: ResApp Health: Update for the quarter ending 31 December 2018

Nov 05, 2018: ResApp receives notice of allowance for core patent in Japan

Aug 16, 2018: ResApp Partners with Lockheed Martin for U.S. Government Agency Research Program

Aug 15, 2018: ResApp receives notice of acceptance for core patent in Australia

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

ResApp Health Ltd, Performance Chart (2015-2019)

ResApp Health Ltd, Ratio Charts

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

ResApp Health Ltd, Key Facts

ResApp Health Ltd, Key Employees

ResApp Health Ltd, Key Employee Biographies

ResApp Health Ltd, Major Products and Services

ResApp Health Ltd, History

ResApp Health Ltd, Subsidiaries

ResApp Health Ltd, Key Competitors

ResApp Health Ltd, Ratios based on current share price

ResApp Health Ltd, Annual Ratios

ResApp Health Ltd, Annual Ratios (Cont...1)

ResApp Health Ltd, Interim Ratios

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

ResApp Health Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

ResApp Health Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

ResApp Health Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Welch Allyn Inc

ResMed Inc

Genetic Signatures Ltd

GE Healthcare LLC

Alere Inc